# Regulatory Compliance in the Respirology Domain

## Overview

Regulatory compliance encompasses the legal, governance, and institutional requirements that shape how the respirology domain model is designed, how data is handled, and how clinical workflows are documented. In Domain-Driven Design, regulatory requirements are cross-cutting concerns that influence aggregate design, event handling, access control, and data retention across all bounded contexts. The respirology domain must comply with healthcare privacy regulations, medical device regulations, clinical documentation standards, and quality reporting requirements.

Regulatory compliance is not a separate bounded context but a set of constraints that permeate the entire domain model. These constraints are enforced through aggregate invariants, domain service validation rules, event metadata requirements, and repository-level access controls.

## HIPAA (Health Insurance Portability and Accountability Act)

### Privacy Rule

HIPAA's Privacy Rule governs the use and disclosure of protected health information (PHI). In the respirology domain, PHI includes patient identifiers, diagnostic results, treatment records, and rehabilitation outcomes. The domain model addresses HIPAA requirements through:

- **Minimum Necessary Principle**: Domain events carry only the data necessary for the consuming context. An AssessmentCompleted event includes clinical summary data relevant to downstream contexts, not the full patient demographic record.
- **Access Authorization**: Repository implementations enforce role-based access. A respiratory therapist can access ventilator configurations but not billing records. A rehabilitation specialist can access functional assessments but not bronchoscopy reports outside their scope.
- **Accounting of Disclosures**: When PHI is shared between bounded contexts through domain events, the event infrastructure logs the disclosure with the data elements shared, the purpose, and the receiving context.

### Security Rule

HIPAA's Security Rule requires administrative, physical, and technical safeguards for electronic PHI. Domain model implications include:

- **Audit Logging**: All aggregate state changes that involve PHI are logged with the user identity, action performed, timestamp, and data elements affected. The Ventilator Configuration aggregate's adjustment history serves dual purposes as clinical documentation and audit trail.
- **Data Integrity**: Value objects enforce data validation at creation, preventing corrupt or incomplete clinical data from entering the system.
- **Emergency Access**: The domain model must support break-the-glass access scenarios where a clinician needs urgent access to data outside their normal authorization scope. Such access is logged and reviewed.

### Breach Notification

The domain model supports breach investigation by maintaining comprehensive event histories that can be queried to determine what data was accessed, by whom, and when.

## FDA Medical Device Regulations

### Software as a Medical Device (SaMD)

Components of the respirology system that provide clinical decision support may be classified as Software as a Medical Device under FDA regulations. This classification affects:

- **Risk Stratification Algorithms**: The RiskStratificationService in the Clinical Assessment Context and the GOLDClassificationService in the Chronic Disease Management Context may qualify as SaMD if they provide diagnostic or treatment recommendations. This requires documentation of intended use, risk classification, and clinical validation.
- **Ventilator Integration**: The Ventilatory Support Context's interface with mechanical ventilators involves medical device data. The anti-corruption layer must maintain data fidelity and the system must document its role in the ventilator management workflow.
- **Change Control**: Domain model changes that affect clinical algorithms must follow a controlled change process with risk assessment, verification, and validation before deployment.

### Device Data Integrity

When the respirology system receives data from medical devices (ventilators, spirometers, pulse oximeters), it must maintain the integrity and traceability of that data:

- Device-originated value objects (SpO2Reading, SpirometryResult, DeviceTelemetry) include metadata about the source device, calibration status, and acquisition timestamp.
- Anti-corruption layers that translate device data preserve the original device readings alongside the translated internal representation.

## Clinical Documentation Requirements

### Documentation Standards

Healthcare institutions and accreditation bodies (such as The Joint Commission) require specific documentation standards that influence aggregate design:

- The Respiratory Assessment aggregate must capture all elements required by institutional documentation policies for a respiratory examination.
- The Airway Procedure aggregate must document pre-procedure assessment, informed consent reference, procedure details, confirmation of placement, and post-procedure assessment.
- The Ventilator Configuration aggregate must maintain a complete log of parameter changes with clinical rationale.

### Documentation Timeliness

Regulatory requirements mandate timely clinical documentation. Domain model implications include:

- Assessment and procedure aggregates track completion timeliness against institutional requirements.
- Domain events for documentation deadlines (e.g., procedure notes due within 24 hours) can trigger workflow reminders.

## Quality Reporting

### Clinical Quality Measures

The respirology domain supports quality measure reporting through its event and aggregate design:

- COPD readmission rates can be calculated from exacerbation records and admission events.
- Ventilator-associated event rates can be derived from ventilator configuration and clinical assessment data.
- Pulmonary rehabilitation completion rates and outcome improvements are tracked by the Rehabilitation Program aggregate.
- Spirometry quality grades support quality assurance for pulmonary function laboratories.

### Meaningful Use and Interoperability

Health information exchange requirements influence the published languages used between contexts and with external systems. HL7 FHIR resource alignment ensures that the respirology system can participate in health information exchanges and meet interoperability mandates.

## Data Retention and Archival

Regulatory requirements specify minimum retention periods for clinical records:

- Repository implementations must support long-term data retention consistent with jurisdictional requirements (typically 7-10 years for adult medical records, longer for minors).
- Archived aggregates must remain retrievable for legal, regulatory, and clinical purposes.
- Event stores must maintain the complete event history for audit and reconstruction purposes.

## Consent Management

Clinical data use in the respirology domain may require specific patient consent:

- Research use of clinical data requires documented consent and IRB approval.
- Telemedicine and remote monitoring (home ventilation telemetry) require specific consent for data transmission.
- Domain events that transmit data to external systems include consent verification as a precondition.

## International Considerations

The respirology domain model should accommodate regulatory variations across jurisdictions:

- GDPR in the European Union imposes additional requirements for data subject rights, data processing agreements, and cross-border data transfer.
- Regional medical device regulations (EU MDR, Health Canada, TGA) may apply to SaMD components.
- Clinical documentation requirements vary by country, state, and institution.

## References

- Evans, E. (2003). *Domain-Driven Design: Tackling Complexity in the Heart of Software*. Addison-Wesley.
- Vernon, V. (2013). *Implementing Domain-Driven Design*. Addison-Wesley.
- Khononov, V. (2021). *Learning Domain-Driven Design*. O'Reilly Media.
- U.S. Department of Health and Human Services. (2013). *HIPAA Administrative Simplification*. 45 CFR Parts 160, 162, and 164.
- U.S. Food and Drug Administration. (2017). *Software as a Medical Device (SaMD): Clinical Evaluation*. Guidance Document.
- International Medical Device Regulators Forum. (2014). *Software as a Medical Device: Key Definitions*. IMDRF/SaMD WG/N10FINAL.
